🇺🇸 FDA
Patent

US 6593359

Use of a RAR-&ggr;-specific agonist ligand for increasing the rate of apoptosis

expired A61KA61K31/192A61P

Quick answer

US patent 6593359 (Use of a RAR-&ggr;-specific agonist ligand for increasing the rate of apoptosis) held by Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma expires Mon Jul 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma
Grant date
Tue Jul 15 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/192, A61P, A61P1/16, A61P17/00